Ostomy Devices Market Size, Share & Industry Analysis, By Product Type (Ostomy Pouching Systems & Components {One-Piece Pouching Systems and Two-Piece Pouching Systems & Components} and Ostomy Accessories & Adjuncts), By Ostomy Type (Colostomy, Ileostomy, and Urostomy), By Age Group (Adults and Pediatric), By End-user (Hospitals & ASCs, Homecare Settings, Specialty Clinics & Long-Term Care Facilities, and Others), and Regional Forecast, 2026-2034

The global ostomy devices market size was valued at USD 3.55 billion in 2025. The market is projected to grow from USD 3.72 billion in 2026 to USD 5.39 billion by 2034, exhibiting a CAGR of 4.8% during the forecast period.

An ostomy device is a medical appliance used to collect and manage bodily waste from an artificial opening in the abdomen called a stoma. These systems typically consist of a pouch and a skin barrier. Market growth is attributed to a rise in the prevalent ostomate population, increasing use of supporting accessories and skin-protection products.

Coloplast A/S, Hollister Incorporated, Convatec, B. Braun SE, and Salts Healthcare held the highest market share in 2025 due to their strong brand reputation and footprint in the key countries worldwide.

OSTOMY DEVICES MARKET TRENDS

Connected Leakage Detection and Digital Ostomy Support to Emerge as a Key Trend

Currently, traditional ostomy pouches are increasingly being integrated with sensors, connectivity, and digital features. These connected systems can detect possible leakage or changes in stoma output and send alerts to users. Early warnings may help reduce leakage-related skin problems and improve users’ confidence in managing their ostomy.

Smart ostomy systems require more stringent regulatory requirements than conventional Class I ostomy pouches, as the addition of sensors and connected technologies may require regulatory review before commercialization. This enhances the overall output of ostomy devices.

• For instance, in October 2025, the U.S. FDA cleared Coloplast’s Heylo System through the traditional 510(k) pathway (K252140) after determining it to be substantially equivalent to an existing legally marketed device.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Growing Ostomate Population and Recurring Product Utilization to Accelerate Market Growth

In recent years, the growing number of people living with an ostomy is creating steady demand for ostomy care products. Ostomy pouches, skin barriers, and accessories need to be replaced regularly. Therefore, every new ostomy surgery adds a new long-term user, while existing ostomates continue purchasing products for many years.

This is creating a stable and recurring source of demand, especially in countries where reimbursement supports regular access to ostomy supplies. This is anticipated to fuel the ostomy devices market growth in the coming years.

• For instance, as of August 2026, the United Ostomy Associations of America (UOAA) estimates that around 725,000-1,000,000 people in the U.S. live with an ostomy, while approximately 100,000 ostomy surgeries are performed each year.

MARKET RESTRAINTS

Reimbursement, Affordability and Pricing Pressure May Limit Market Expansion

Patients need to purchase pouches and related accessories regularly, so reimbursement limits, co-payments, tender prices, and out-of-pocket costs strongly influence product choice. In developed markets, manufacturers are facing pricing pressure from government reimbursement reviews and procurement programs. In emerging markets, limited insurance coverage is reducing the frequency of product replacement or encouraging patients to choose lower-cost products.

• For instance, in Australia, expenditure under the Stoma Appliance Scheme increased from approximately USD 88.1 million in 2013 to USD 75.1 million in 2024.

While such reimbursement programs improve patient access to ostomy supplies, the rising expenditure may also encourage governments to regularly review product prices, usage levels, and reimbursement eligibility. This is expected to hinder market growth over the forecast period.

MARKET OPPORTUNITIES

Growing Demand for Ostomy Accessories and Skin-Protection Products to Create Growth Opportunities

In recent years, the growing use of ostomy accessories has created an important opportunity for market growth. Products such as barrier rings, seals, pastes, adhesive removers, deodorants, and skin protectants help prevent leakage, protect the skin around the stoma, and improve patient comfort. These products are usually used along with ostomy pouches, allowing companies to generate additional revenue without requiring patients to change their main pouching system.

For instance, in the 2024/25 financial results, Coloplast A/S estimated that the supporting products witnessed a growth of 6.0% - 8.0% year-on-year.

MARKET CHALLENGES

Leakage, Skin Problems, and Difficulty in Achieving the Right Fit to Challenge Market Growth

Every patient has a different stoma shape, body contour, skin condition, and output type, making it difficult to achieve a secure and comfortable fit. Poor fitting can lead to leakage, skin damage around the stoma, frequent pouch changes, and even switching between brands. This creates a continuous need for manufacturers to develop better-fitting products, including convex pouches, flexible barriers, improved moisture control, and skin-friendly adhesives.

For instance, in July 2025, ALCARE reported that 34.9% of 3,930 ostomates surveyed in Japan experienced problems related to stool or urine leakage or odor. This is anticipated to limit market expansion over the forecast period.

Segmentation Analysis

By Product Type

Ostomy Pouching Systems & Components Led Market Due to Their Increased Usage for External Collection After Stoma Creation

Based on product type, the market is segmented into ostomy pouching systems & components and ostomy accessories & adjuncts. The ostomy pouching systems & components segment is sub-segmented into one-piece pouching systems and two-piece pouching systems & components.

The ostomy pouching systems & components segment accounted for the largest ostomy devices market share in 2025. Pouching systems are indispensable for external collection after stoma creation, so nearly every actively managed ostomate generates recurring pouch and barrier consumption. Moreover, manufacturer portfolios remain centered on one- and two-piece systems, which is driving segment growth.

The ostomy accessories & adjuncts segment is projected to grow at a 6.2% CAGR during the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Ostomy Type

Colostomy Segment Led Market Due to Large Population Undergoing Permanent or Temporary Fecal Diversion

By ostomy type, the market is segmented into colostomy, ileostomy, and urostomy.

The colostomy segment accounted for the largest market share in 2025. The segment growth is attributed to the large population undergoing permanent or temporary fecal diversion for colorectal cancer, diverticular disease, bowel obstruction, trauma, and other colorectal conditions. This drives the recurring use of closed or drainable pouch systems. Moreover, the segment is expected to hold a 52.1% share in 2026.

The ileostomy segment is anticipated to grow at a CAGR of 5.3% over the forecast period.

By Age Group

Rising Geriatric Population Boosted Adults Segment Growth

By age group, the market is classified into adults and pediatric.

The adults segment accounted for the largest market share in 2025. Adult users represent the bulk of long-duration permanent ostomy care, creating sustained pouch and accessory consumption. As a result, the growing aging population is anticipated to drive the segment’s growth during the forecast period.

• For instance, according to the data published by the World Health Organization (WHO) in October 2025, the proportion of the world's population over 60 years is expected to nearly double from 12.0% in 2015 to 22.0% by 2050.

The pediatric segment is expected to grow at a CAGR of 2.8% during the forecast period.

By End-user

Higher Volume of Patients Managing Stoma at Home Fueled Homecare Settings Segment Growth

On the basis of end-user, the market is segmented into hospitals & ASCs, homecare settings, specialty clinics & long-term care facilities, and others.

In 2025, the homecare settings segment dominated the market, as most patients manage their stoma at home after leaving the hospital. Patients regularly change ostomy pouches, skin barriers, and accessories at home. Moreover, government reimbursement programs also support home-based use of ostomy products. Furthermore, the segment is set to hold a 73.6% market share in 2026.

• For instance, as of August 2026, Australia’s Stoma Appliance Scheme supports around 50,000 people and provides subsidies for thousands of ostomy products, helping patients access the supplies they need for long-term home care.

The hospitals & ASCs segment is projected to grow at a CAGR of 3.5% during the forecast period.

Ostomy Devices Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest share in 2024, valued at USD 1.24 billion, and maintained its leading position in 2025, with USD 1.29 billion. A large established ostomate base, extensive home-use supply consumption, mature pharmacy distribution, and Medicare coverage support the region’s dominance.

U.S. Ostomy Devices Market

In 2026, the U.S. is anticipated to reach USD 1.23 billion, accounting for approximately 33.2% of global sales.

Europe

Europe is projected to record a CAGR of 3.8% during the forecast period, the second-highest globally. The market is expected to reach USD 1.21 billion in 2026. Market growth is supported by strong reimbursement systems, established stoma-care services, and the presence of major ostomy product manufacturers.

• For instance, in August 2025, Colostomy UK stated that more than 200,000 people in the U.K. were living with a stoma.

U.K. Ostomy Devices Market

The U.K. market is projected to reach USD 0.22 billion in 2026, representing approximately 6.0% of global sales.

Germany Ostomy Devices Market

The market in Germany is expected to reach USD 0.24 billion in 2026, accounting for approximately 6.5% of global revenues.

Asia Pacific

In 2026, Asia Pacific is projected to reach approximately USD 0.80 billion, making it the third-largest market. The region’s growth is led by China, India, and Southeast Asia, where large populations, increasing access to colorectal and urological surgery, and rising healthcare spending are improving the availability of modern pouching systems.

Japan Ostomy Devices Market

The market in Japan is projected to reach approximately USD 0.20 billion in 2026, representing nearly 5.3% of global sales.

China Ostomy Devices Market

In 2026, the market in China is anticipated to reach USD 0.24 billion, accounting for approximately 6.6% of global sales.

India Ostomy Devices Market

In 2026, the market in India is anticipated to reach USD 0.12 billion, accounting for approximately 3.2% of global sales.

Latin America and Middle East & Africa

Latin America and the Middle East & Africa are anticipated to witness moderate growth during the forecast period. The market in Latin America is estimated to reach approximately USD 0.20 billion in 2026, supported by increasing product availability. Moreover, market growth in the Middle East & Africa is mainly due to increasing awareness of ostomy devices, supported by a large patient pool in the region.

GCC Ostomy Devices Market

In 2026, the GCC market is estimated to reach approximately USD 0.06 billion, representing around 1.7% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Focus on Skilled Nursing, Geographic Expansion, and Acquisitions to Enhance Market Share of Key Companies

In 2025, Coloplast A/S, Hollister Incorporated, Convatec, B. Braun SE, and Salts Healthcare held the largest global market share. The growth of these companies is attributed to their broad pouching-system and accessory portfolios, established distribution networks, and strong presence across major regions. Other prominent players are focusing on various growth strategies such as facility expansion in underserved regions. Also, they are involved in collaborations, acquisitions, and partnerships to expand their market share.

LIST OF KEY OSTOMY DEVICE COMPANIES PROFILED

• Coloplast A/S (Denmark)
• Hollister Incorporated (U.S.)
• Convatec (U.K.)
• Braun SE (Germany)
• Salts Healthcare (U.K.)
• Eakin Healthcare Group (U.K.)
• Welland Medical Limited (U.K.)
• ALCARE Co., Ltd. (Japan)
• Unora Healthcare Ltd. (U.K.)
• Cymed (U.S.)

KEY INDUSTRY DEVELOPMENTS

• April 2026: ForLife and Oakmed announced their rebrand to Unora Healthcare Ltd alongside the launch of Silkura, a silicone-based ostomy pouch featuring breathable skin protection, adaptive adhesion and atraumatic removal.
• February 2026: Convatec disclosed a second U.S. Ostomy Care GPO win with Premier Inc., following its Captis/Vizient win in late 2025.
• November 2025: Convatec secured its first U.S. ostomy Group Purchasing Organization contract in more than five years through Vizient.
• July 2025: ALCARE Co., Ltd. launched DeoQuick Spray, a deodorizing product specifically developed for ostomates and usable inside ostomy appliances, on clothing and in surrounding spaces.
• March 2025: Convatec announced a global collaboration with the Wound, Ostomy, and Continence Nurses Society (WOCN) to offer free advanced ostomy-care education programs. The initiative targeted training more than 750 additional HCPs.
• February 2025: Welland Medical Limited announced that its Manuka honey-infused ostomy products had received Skin Health Alliance accreditation.
• December 2024: Duke Street acquired ForLife Group and the ostomy-care assets of Trio Healthcare. The transaction combined ForLife's German manufacturing and Oakmed distribution presence with Trio's Genii products and Sil2 silicone technology.
• June 2024: Welland Medical Limited and Canadian Distributor Premier Ostomy showcased Welland's stoma-care products at the 43rd NSWOCC Conference.

REPORT COVERAGE

The report provides detailed analysis of the global ostomy devices market across its key segments, examining the major drivers, trends, opportunities, restraints, and challenges. It also highlights key industry developments, the number of key procedures, a detailed competitive landscape, market share analysis, and company profiles of the major companies operating in the market.

Request for Customization   to gain extensive market insights.

Report Scope and Segmentation

Research Methodology

1. Bottom Up Approaches

Approach 1:  Revenues and Market Share of Major Ostomy Device Players

• Collection of ostomy-care-specific revenues from annual reports, investor presentations, earnings releases, company filings, official company disclosures, and product portfolios.
• Analysis of leading companies such as Coloplast A/S, Hollister Incorporated, Convatec Group Plc, B. Braun SE, Salts Healthcare Ltd., Eakin Healthcare Group, Welland Medical Ltd., ALCARE Co., Ltd., Unora GmbH / Unora Healthcare Ltd., Marlen Manufacturing, Safe n Simple, OxMed, Cymed, Nu-Hope Laboratories, and Ostoform.
• Estimation of company-level ostomy revenues based on disclosed Ostomy Care sales, product portfolio breadth, geographic exposure, distribution reach, reimbursement access, institutional procurement presence, and homecare penetration.
• Allocation of only revenues attributable to in-scope ostomy pouching systems, components, accessories, and adjuncts, excluding wound care, continence care, surgical products, and other unrelated businesses.
• Adjustment for distributor sales, licensing arrangements, private-label relationships, acquisitions, and subsidiary-level revenues to avoid double counting across companies.
• Assessment of manufacturer market positioning using pouching-system portfolio strength, installed user base, country presence, product launches, reimbursement coverage, and procurement contracts.
• Triangulation of company-level ostomy revenues with product-level utilization, ostomate populations, and country-level consumption to derive the global market estimate.

Approach 2: Product-Level Sales, Utilization and Pricing Analysis

• Identification of commercially available ostomy pouching systems and adjunct products across one-piece systems, two-piece systems & components, and ostomy accessories.
• Mapping of major product families such as Coloplast SenSura Mio, Convatec Esteem and Natura, Hollister CeraPlus/New Image/Premier, B. Braun Flexima/Almarys, Salts Confidence, Welland Aurum, Eakin products, ALCARE ostomy systems, and other relevant portfolios.
• Collection and benchmarking of manufacturer selling prices for one-piece pouches, two-piece pouches, skin barriers/baseplates, barrier rings, seals, pastes, adhesive removers, belts, and other ostomy accessories.
• Estimation of average pouch-change frequency, barrier-change frequency, accessory-use frequency, pack size, annual unit consumption, and annual spending per ostomate.
• Assessment of product mix across one-piece versus two-piece systems, standard versus premium products, flat versus convex solutions, extended-wear barriers, and accessory penetration.
• Calculation of product-level market value using annual units consumed × manufacturer selling price across major countries and regions.
• Aggregation of product-level revenues across colostomy, ileostomy, and urostomy applications to estimate regional and global market values.
• Adjustment of forecast utilization for premiumization, advanced skin-barrier adoption, convex-product penetration, connected ostomy technologies, reimbursement changes, and price pressure.

Approach 3:  Ostomate Population, Procedure and Consumption Model

• Assessment of prevalent ostomate populations across the U.S., Canada, major European countries, Japan, China, India, Australia, Southeast Asia, Latin America, and the Middle East & Africa.
• Estimation of annual new colostomy, ileostomy, and urostomy procedures based on colorectal cancer, inflammatory bowel disease, bladder cancer, congenital disorders, trauma, and other relevant clinical indications.
• Assessment of permanent versus temporary stoma populations, annual reversal rates, mortality, new-patient additions, and prevalent-patient retention.
• Mapping of the ostomate population by ostomy type, age group, and end-user setting to align directly with the study segmentation.
• Application of country-specific pouching-system adoption, one-piece/two-piece mix, average replacement frequency, accessory utilization, and product availability.
• Calculation of average annual ostomy device expenditure per patient using manufacturer-level prices rather than retail prices or reimbursement values.
• Multiplication of addressable ostomate population by annual device consumption and manufacturer-level revenue per patient for each country.
• Aggregation of country-level estimates to regional and global market values, followed by reconciliation with company revenues and reported market positions.

2. Top Down Approaches

Approach 1: Country-Level Per-Capita Ostomy Device Spending and Addressable Market Analysis

• Assessment of annual ostomy-device spending per ostomate across countries within the study scope.
• Benchmarking of expenditure based on reimbursement coverage, allowable quantities, insurance penetration, disposable income, healthcare expenditure, product availability, and premium-product adoption.
• Comparison of mature markets such as the U.S., U.K., Germany, France, Japan, and Australia with emerging markets such as China, India, Brazil, Mexico, Southeast Asia, and GCC countries.
• Estimation of country-level addressable expenditure by multiplying the ostomate population by annual manufacturer-level ostomy-product spending per patient.
• Adjustment for differences in pouch-change frequency, accessory usage, one-piece/two-piece product mix, local manufacturing, import dependency, tender pricing, and reimbursement restrictions.
• Cross-checking country-level spending against national healthcare expenditure, medical-consumables spending, reimbursement schedules, procurement data, and manufacturer geographic revenue exposure.
• Summation of country-level market estimates to derive regional and global market values..

Approach 1: Country-Level Per-Capita Ostomy Device Spending and Addressable Market Analysis

• Analysis of relevant medical consumables, homecare supplies, wound/ostomy/continence product spending, and reimbursement pools as broad addressable reference markets.
• Estimation of the portion attributable specifically to ostomy pouching systems, barriers, accessories, and adjunct products.
• Separation of ostomy-device revenues from continence products, wound-care products, surgical services, home healthcare services, and other non-ostomy expenditure.
• Assessment of ostomy's share of recurring medical-supply spending using ostomate prevalence, utilization frequency, reimbursement allowances, and manufacturer disclosures.
• Comparison of the resulting top-down estimate with company revenue, product-level sales, per-patient spending, and epidemiology-based models.
• Use of this approach primarily as a validation mechanism to identify potential overestimation or underestimation in the bottom-up market model.

3. Triangulation, Validation and Forecast Modeling

• Comparison of estimates generated from company revenues, product-level utilization, ostomate-population modeling, per-capita spending, and parent-market cross-checks.
• Reconciliation of differences among approaches through country-level reviews of prevalence, reimbursement, pricing, product consumption, and competitive penetration.
• Validation of the 2025 base-year market against disclosed ostomy revenues of major manufacturers and their stated market positions.
• Development of country-specific 2026-2034 growth rates based on ostomate population growth, new ostomy procedures, colorectal and bladder cancer burden, IBD trends, aging demographics, reimbursement changes, and healthcare access.
• Incorporation of changes in one-piece/two-piece mix, accessory penetration, convex-product adoption, advanced skin barriers, premium products, and connected ostomy technologies.
• Adjustment for price inflation, tender pressure, reimbursement revisions, local manufacturing, lower-cost competition, distribution expansion, and changes in manufacturer selling prices.
• Validation of regional and country forecasts against company guidance, product launches, geographic expansion, institutional procurement contracts, reimbursement developments, and historical sales trends.
• Final aggregation of country forecasts into regional and global estimates, with all Product Type, Ostomy Type, Age Group, and End User splits independently reconciling to 100%.

4. List of Key Sources

• Annual reports, investor presentations, earnings releases, financial statements, company filings, and ostomy-specific revenue disclosures
• Official product portfolios, product catalogs, technical brochures, reimbursement guides, and manufacturer websites
• Coloplast A/S, Hollister Incorporated, Convatec Group Plc, B. Braun SE, Salts Healthcare, Eakin Healthcare Group, Welland Medical, ALCARE, Unora, and other in-scope company disclosures
• S. Food and Drug Administration (FDA)
• Centers for Medicare & Medicaid Services (CMS) and Medicare ostomy-supply reimbursement schedules
• European Commission, EU MDR, EUDAMED-related regulatory information, and national European medical-device authorities
• NHS, Drug Tariff, NHS Supply Chain, and other U.K. reimbursement/procurement sources
• PMDA and Ministry of Health, Labour and Welfare, Japan
• NMPA and relevant Chinese healthcare/reimbursement authorities
• CDSCO and Ministry of Health & Family Welfare, India
• Therapeutic Goods Administration (TGA), Australia
• Australian Medicare, PBS-related healthcare information, and national ostomy-supply programs
• United Ostomy Associations of America (UOAA)
• International Ostomy Association and European Ostomy Association
• World Council of Enterostomal Therapists
• Wound, Ostomy and Continence Nurses Society and other national stoma-care organizations
• National ostomy associations and patient-support organizations
• WHO, OECD, Eurostat, World Bank, and national ministries of health
• National cancer registries and colorectal, bladder cancer, and inflammatory bowel disease statistics
• National hospital procedure, discharge, surgery, and healthcare-utilization databases
• Government reimbursement schedules, procurement portals, tender databases, and medical-supply benefit programs
• Peer-reviewed epidemiological studies, clinical guidelines, stoma-care publications, and patient-utilization studies
• Product launches, regulatory approvals, distribution agreements, acquisitions, partnerships, geographic expansions, and reimbursement developments

5. Primary Interviews

Supply Side Interviews: 60%

• Key Respondents:
  • Ostomy device manufacturers
  • Product development and R&D executives
  • Business development and corporate strategy executives
  • Commercial, marketing, product, and sales managers
  • Regional and country sales heads
  • Regulatory affairs and quality-management professionals
  • Market-access and reimbursement specialists
  • Manufacturing and supply-chain executives
  • Ostomy product distributors and DME suppliers
  • Medical-supply wholesalers
  • Hospital and institutional procurement representatives
  • Pharmacy and homecare distribution partners

Demand Side Interviews: 40%

• Key Respondents:
  • Colorectal surgeons
  • Urologists
  • General surgeons involved in ostomy creation and follow-up
  • Wound, ostomy and continence nurses
  • Enterostomal therapy nurses
  • Hospital stoma-care teams
  • Homecare nurses and ostomy-care providers
  • Specialty-clinic administrators
  • Long-term care facility professionals
  • Ostomates and patient-support organizations
  • Payers and reimbursement specialists
  • Public procurement and medical-supply program authorities
  • Hospital formulary and procurement managers